Related Experiment Video
Updated: Oct 10, 2026
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Anti-tumor potential of bisphosphonates
1Novartis Pharma AG, Basel, Switzerland. jonathan.green@pharma.novartis.com
Abstract:
In addition to inhibiting bone resorption, bisphosphonates also exert anti-tumor effects. The most potent compounds are the newer, nitrogen-containing bisphosphonates such as zoledronic acid. In vitro, bisphosphonates inhibit proliferation and induce apoptosis in human tumor cell lines, and interfere with cell adhesion, invasion and growth factor secretion. The combination of bisphosphonates with other anti-cancer drugs such as paclitaxel or tamoxifen markedly enhances these effects. In vivo, zoledronic acid has recently been shown to inhibit angiogenesis. Although bisphosphonates are very effective against bone metastases, their in vivo anti-tumor potential against visceral metastases remains to be explored.
Insights
Nitrogen-containing bisphosphonates, like zoledronic acid, show potent anti-tumor effects by inhibiting cancer cell growth and promoting cell death. Their efficacy against bone metastases is established, but potential against visceral metastases requires further investigation.
Area of Science:
- Oncology
- Pharmacology
- Cancer Biology
Background:
- Bisphosphonates are known for inhibiting bone resorption.
- Emerging evidence suggests significant anti-tumor properties for bisphosphonates, particularly nitrogen-containing compounds.
Purpose of the Study:
- To review the anti-tumor effects of bisphosphonates, focusing on nitrogen-containing agents like zoledronic acid.
- To explore the in vitro and in vivo mechanisms of action and potential therapeutic applications of bisphosphonates in cancer treatment.
Main Methods:
- In vitro studies assessing bisphosphonate effects on human tumor cell lines (proliferation, apoptosis, adhesion, invasion, growth factor secretion).
- Evaluation of combination therapies with other anti-cancer drugs (paclitaxel, tamoxifen).
- In vivo studies examining zoledronic acid's effect on angiogenesis.
Main Results:
- Bisphosphonates inhibit tumor cell proliferation and induce apoptosis in vitro.
- Combination therapy with bisphosphonates and other anti-cancer drugs enhances anti-tumor effects.
- Zoledronic acid demonstrates in vivo inhibition of angiogenesis.
Conclusions:
- Nitrogen-containing bisphosphonates exhibit potent anti-tumor activities, including anti-proliferation, pro-apoptosis, and anti-angiogenesis effects.
- Bisphosphonates are effective against bone metastases, but their anti-tumor potential against visceral metastases needs further exploration.
